4.9 • 3.3K Ratings
🗓️ 8 April 2022
⏱️ 13 minutes
🧾️ Download transcript
Click on a timestamp to play from that location
0:00.0 | It's booster season again, booster mania. |
0:03.9 | At the highway here, we reported on the story as it was breaking at the highwayer.com news |
0:08.1 | section FDA authorizes fourth fifth booster doses for various groups and ages bypasses |
0:13.4 | expert vote. |
0:14.8 | What they did was they allowed what they called a second booster of Pfizer Moderna for |
0:18.8 | 50 and overs. |
0:20.1 | They allowed Pfizer booster a second booster. |
0:23.0 | I should say this is their language of Pfizer for 12 and over immunocompromised and a second |
0:28.2 | booster for 18 and overs for Moderna. |
0:31.1 | Now what's interesting about this was the science and the medical community has already |
0:36.7 | been at an uproar reported on this since basically eight months since August since the first |
0:40.9 | boosters being rolling out. |
0:42.5 | They continually bypass this committee and has been no different this time. |
0:46.1 | Johns Hopkins, Marty McCarrie, he's a surgeon public policy researcher at the university. |
0:51.6 | He took to Twitter and just blasted the CDC and the FDA. |
0:55.5 | There is zero clinical data that a fourth dose reduces hospitalization risk. |
0:59.7 | There isn't even any evidence that a third dose reduces hospitalization risk in young |
1:03.7 | people. |
1:04.7 | He goes on to say political interference over boosters was the issue behind two high level FDA |
1:08.8 | departures in the fall. |
1:10.2 | There is no greater slap in the face of science than bypassing the customary FDA external |
1:14.6 | expert voting process over an authorization with insufficient supporting clinical data. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from The Highwire with Del Bigtree, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of The Highwire with Del Bigtree and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2025.